Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.15.1 (
ACE
)
18,300
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The results of 26 consecutive thoracolumbar fractures treated with Cotrel-Dubousset instrumentation (CDI) (n = 12) or the
ACE
Posterior Segmental Fixator (n = 14) with a mean follow up of 20.2 months were analyzed. Preoperatively, no statistically significant difference was noted between the two treatment groups. Postoperatively, no statistically significant difference was noted for improvement of kyphosis (mean: -6.00 degrees
ACE
, 1.92 degrees CDI), vertebral body height (mean: 17.86%
ACE
, 18.83% CDI), vertebral body angle (mean: -6.21 degrees
ACE
, -5.42 degrees CDI), or estimated blood loss (mean: 1544 cc
ACE
, 1620 cc CDI). All patients with
incomplete paraplegia
improved by at least one Frankel grade. Statistically significant differences were noted in operative time (mean: 269 minutes
ACE
, 357 minutes CDI, P < .0005), and in the number of instrumented levels (mean: 3
ACE
, 5.8 CDI). All patients exhibited solid fusion radiographically. Thoracolumbar fractures can be effectively treated by either CDI or the
ACE
Fixator. The
ACE
Fixator has the advantage of sparing motion segments and decreased operative time.
...
PMID:A comparison study of treatment of thoracolumbar fractures using the ACE Posterior Segmental Fixator and Cotrel-Dubousset instrumentation. 747 8